Novel Drug Approvals for 2025 Each year, the U.S. Food and Drug Administration (FDA) reviews and approves a select group of new medications known as “novel” drugs—those that have never before been approved or marketed in the United States. These drugs often represent significant scientific and clinical advances, offering new treatment options for diseases with … Continue reading FDA Novel Drug Therapy Approvals for 2025 | Quarter 1